The waiver applies to all commercial, individual and Medicare plan members, according to a press release.
“The pandemic is still very real,” said the payer’s CMO, Mark Steffen, MD. “With hospitalizations over the last month at the highest levels we have seen in 2021, we need to remain vigilant.”
A number of payers stopped waiving costs of COVID-19 treatments earlier this year.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
